Aims Compared with those without obesity, patients with obesity‐related heart failure with preserved ejection fraction (HFpEF) have worse symptoms, haemodynamics, and outcomes …
S Takeuchi, T Kohno, A Goda, Y Shiraishi… - International Journal of …, 2023 - Elsevier
Background Despite the benefits of the sodium-glucose cotransporter 2 inhibitor (SGLT2i) empagliflozin, its suitability for patients with heart failure (HF) in the real-world setting …
T Kondo, R Campbell, PS Jhund, IS Anand… - JACC: Heart Failure, 2024 - Elsevier
Background Although some patients with heart failure (HF) with mildly reduced/preserved ejection fraction have low natriuretic peptide levels, there are no large-scale systematic …
Aims Clinical trials in heart failure with mildly reduced or preserved ejection fraction (HFmrEF/HFpEF) commonly have detailed eligibility criteria. This may contribute to …
RB Patel, SJ Shah - Journal of cardiac failure, 2022 - Elsevier
Heart failure (HF) with preserved ejection fraction (HFpEF) is a heterogeneous clinical syndrome that results in resting or exertional left atrial pressure elevation with concomitant …
Given recent advances in therapeutic options for heart failure with preserved ejection fraction (HFpEF), noninvasive screening and diagnostic tools are critical to accurately …
CS Morgen, CL Haase, TK Oral, V Schnecke… - Mayo Clinic …, 2023 - Elsevier
Objective To compare clinical features of patients with obesity-related heart failure (HF) with preserved ejection fraction (HFpEF) with those of patients with similar body mass index …